• News and Events

    • Information Management Needs Proper Governance

      2016-8-18

      PharmaPhorum

      Data has become life sciences companies’ biggest corporate asset. Therefore, clean, properly governed data can make (or conversely break) an organisation. Learn more about this important aspect of information management in the second article of a three-part series.

    • Why Multichannel is not an in/out Option

      2016-8-15

      Pharmaceutical Market Europe (PME)

      PME sites IMS Health’s Gareth Dabbs, Principal, Technology and Services, in its examination of why European pharmaceutical companies have been slow to adopt multichannel strategies, and the imperative to embrace technology as they progress.

    • Multichannel: The Essential European Revolution

      2016-8-12

      Pharmaceutical Market Europe (PME)

      Sarah Rickwood, VP, European Thought Leadership for IMS Health, contributes her analysis of the use of multichannel and digital strategies by European pharmaceutical companies, versus other mature markets, and offers implementation success factors.

    • Information Management: Gaining Value from Data

      2016-7-26

      PharmaPhorum

      In the first of three guest blogs from IMS Health on information management, Mike Allelunas, GM of Information Management, advises life sciences companies to rethink their master data management (MDM) strategies, and define long-term enterprise information management (EIM) strategies.

    • Transforming Technology: The Future of the CIO in the Life Sciences

      2016-7-13

      Pharmaceutical Executive

      Pharm Exec editor-in-chief, Bill Looney, recently moderated a CIO roundtable discussion on how technology is transforming the life sciences industry, as well as the role of C-level technology executives. 

    • IMS Health and Reltio Tighten their Collaboration

      2016-6-16

      Pharmaceutical Commerce

      The alliance between IMS Health and Reltio will provide the life sciences industry with advanced big data technologies, high-performance analytics and healthcare information capabilities.

    • Transformational Technology: Big Data, The Cloud and the Value of Insights

      2016-5-2

      Pharmaceutical Market Europe

      The advent of the big data era has produced a big challenge for pharma and, with the continued growth and influence of mobile, wearable devices, machine learning and the internet-of-things, the size of the challenge won’t be shrinking any time soon.

    • Pharma Needs Hybrid Sales and Marketing Rep

      2016-4-18

      PharmaPhorum

      Pharma can achieve substantially improved commercial effectiveness by orchestrating a truly integrated effort between sales and marketing teams.  

    • U.S. prescription drug spending to hit $400 billion a year by 2020: IMS

      2016-4-14

      Reuters

      U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc on Thursday.

    • Prescription Drug Spending Hits Record $425 Billion in U.S.

      2016-4-14

      Bloomberg

      Spending on prescription drugs in the U.S. rose 12 percent to a record $425 billion before discounts last year, boosted in part by the introduction of breakthrough medicines for cancer and the growing number of patients seeking treatment for hepatitis C.

    • U.S. Drug Spending Climbs

      2016-4-14

      Wall Street Journal

      Total spending on prescription drugs in the U.S. rose 12.2% to nearly $425 billion in 2015, continuing a steep climb fueled by the introduction in recent years of expensive new drugs for cancer and infections, as well as price hikes for older drugs, according to a new report.

See More